ClinicalTrials.gg
CompletedNCT03381027BabySMARTUpdated Oct 28, 2020

BABY SMART (Study of Massage Therapy, Sleep And neurodevelopMenT)

An interventional study of Baby Massage in Sleep and Neurodevelopmental Disorders, sponsored by University College Cork. Completed at 1 site in Ireland. Open to participants aged 37 Weeks to 42 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-10-28.

Sponsored by University College Cork · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jun 2017, registered Dec 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
408
Allocation
Randomized
Ages
37 Weeks to 42 Weeks
Sex
All
01

Study summary

It is well known that sleep is essential for brain development and learning. Infants require extensive sleep for development of the hippocampus, pons, brainstem, and midbrain and for optimizing physical growth. It is also essential for brain plasticity; the genetically determined ability of the infant brain to change its structure and function in response to the environment. Studies in young animals have shown that sleep deprivation leads to increased programmed cell death, smaller brain size, and loss of brain plasticity, all of which have negative long-term impact on behaviour and learning ability.

Infant massage, a form of systematic tactile stimulation by human hands, improves sleep hygiene. Very little is known about how massage influences early brain development but it is certainly linked to the theory of environmental enrichment, which has been well established in animal models.

The aim of this project is to optimise the infant's sensory experience through a multi-sensory enrichment programme, including massage (a massage utilising a scented lotion before sleep each day), to encourage more structured sleep and ultimately show improved developmental and cognitive outcomes.

Read the detailed description

See study protocol attached.

02

Conditions studied

  • Sleep
  • Neurodevelopmental Disorders

Keywords

  • Infant Sleep
  • Baby Massage
  • Neurodevelopmental Disorders
03

In context

Neurodevelopmental Disorders

352 studies on the registry are indexed under Neurodevelopmental Disorders; 141 are open to participants now.

This study's enrollment of 408 is above the median of 88 across 217 interventional studies indexed under Neurodevelopmental Disorders.

Browse Neurodevelopmental Disorders studies →

Lead sponsor

University College Cork is the lead sponsor of 119 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
37 Weeks to 42 Weeks
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Infants born > 37 weeks gestation
  2. Single births
  3. Not requiring admission to the Neonatal Unit
  4. Healthy infants without suspected congenital or metabolic anomalies

Exclusion criteria

Exclusion Criteria:

  1. Infants born \< 37 weeks gestation
  2. Multiple births
  3. Severe metabolic or genetic anomaly that would require ongoing specialist care in the infancy period.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
408 participants (actual)

Study arms

  • Experimental
    Interventional Arm- Baby Massage

    Interventional Arm= Baby Massage

    Procedure: Baby Massage

  • No intervention
    Control Arm- no Baby Massage

    Control Arm= no Baby Massage

Interventions

  • ProcedureBaby Massage

    Structured massage of the baby

06

What researchers measure

Primary outcomes

  1. Infant sleep measured by video EEG length of sleep cycles

    Sleep EEG

    Time frame: assessment carried out in fourth month of life

Secondary outcomes

  1. Neuro-development measured by Griffiths 3 Developmental Assessment

    Griffiths 3 Developmental Assessment

    Time frame: Assessment carried out at 4 & 18 month of life

07

Study locations

1 site
  • Cork University Maternity Hospital
    Cork, Munster, Ireland
08

References and documents

Publications

  • Ventura S, Mathieson SR, O'Toole JM, Livingstone V, Ryan MA, Boylan GB. Electroencephalographic sleep macrostructure and sleep spindles in early infancy. Sleep. 2022 Jan 11;45(1):zsab262. doi: 10.1093/sleep/zsab262. PubMed 34755881 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2017 to primary completion in Dec 2019, 30 months.

Of 142 non-industry interventional studies with no phase under Neurodevelopmental Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 52. This study's 30 months is close to that.

Counting every sponsor, half of 148 studies reached it within 30 months; a quarter within 15 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2017
First posted
Dec 21, 2017
StartActual
Jun 5, 2017
Primary completionActual
Dec 16, 2019
CompletionActual
Jun 9, 2020
Last update
Oct 28, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 28, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03381027
Responsible party
Professor Geraldine Boylan (Professor Geraldine Boylan INFANT Centre Director, University College Cork) — Principal investigator
First posted
Dec 21, 2017
Start date
Jun 5, 2017
Primary completion
Dec 16, 2019
Completion
Jun 9, 2020
Last update
Oct 28, 2020

Study contacts

Geraldine Boylan, PhD
principal investigator · INFANT UCC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion